Tumor-infiltrating CD8+ T cell antitumor efficacy and exhaustion: molecular insights

被引：39
|
作者：
Kumar, Sandeep [1 ]
Singh, Sunil Kumar [1 ]
Rana, Basabi [1 ,2 ,3 ]
Rana, Ajay [1 ,2 ,3 ]
机构：
[1] Univ Illinois, Div Surg Oncol, Dept Surg, Chicago, IL 60612 USA
[2] Univ Illinois, Univ Illinois Hosp & Hlth Sci Syst Canc Ctr, Chicago, IL 60612 USA
[3] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA
来源：
DRUG DISCOVERY TODAY | 2021年 / 26卷 / 04期
关键词：
INTRATUMORAL IMMUNOTHERAPY; LYMPHOCYTE THERAPY; PHOSPHORYLATED ERK; PD-1; BLOCKADE; LUNG-CANCER; CHECKPOINT; MELANOMA; IMMUNITY; ANTIGEN; AGONIST;
D O I：
10.1016/j.drudis.2021.01.002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Host immunity has an essential role in the clinical management of cancers. Therefore, it is advantageous to choose therapies that can promote tumor cell death and concurrently boost host immunity. The dynamic tumor microenvironment (TME) determines whether an antineoplastic drug will elicit favorable or disparaging immune responses from tumor-infiltrating lymphocytes (TILs). CD8+ T cells are one of the primary tumor-infiltrating immune cells that deliver antitumor responses. Here, we review the influence of various factors in the TME on CD8+ T cell exhaustion and survival, and possible strategies for restoring CD8+ T cell effector function through immunotherapy.
引用
收藏
页码：951 / 967
页数：17
相关论文
共 50 条
  • [1] CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells
    Canale, Fernando P.
    Ramello, Maria C.
    Nunez, Nicolas
    Furlan, Cintia L. Araujo
    Bossio, Sabrina N.
    Serran, Melisa Gorosito
    Boari, Jimena Tosello
    del Castillo, Andres
    Ledesma, Marta
    Sedlik, Christine
    Piaggio, Eliane
    Gruppi, Adriana
    Rodriguez, Eva V. Acosta
    Montes, Carolina L.
    CANCER RESEARCH, 2018, 78 (01) : 115 - 128
  • [2] Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells
    Mognol, Giuliana P.
    Spreafico, Roberto
    Wong, Victor
    Scott-Browne, James P.
    Togher, Susan
    Hoffmann, Alexander
    Hogan, Patrick G.
    Rao, Anjana
    Trifari, Sara
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (13) : E2776 - E2785
  • [3] CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells-Response
    Canale, Fernando P.
    Ramello, Maria C.
    Nunez, Nicolas
    Bossio, Sabrina N.
    Piaggio, Eliane
    Gruppi, Adriana
    Rodriguez, Eva V. Acosta
    Montes, Carolina L.
    CANCER RESEARCH, 2018, 78 (17) : 5175 - 5175
  • [4] CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells-Letter
    Thelen, Martin
    Lechner, Axel
    Wennhold, Kerstin
    von Bergwelt-Baildon, Michael
    Schloesser, Hans A.
    CANCER RESEARCH, 2018, 78 (17) : 5173 - 5174
  • [5] Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8+ T cell augmentation
    Chuan-Kun Shan
    Yi-Bo Du
    Xiao-Tian Zhai
    Yue-Xuan Wang
    Yi Li
    Jian-Hua Gong
    Zhi-Juan Ge
    Xiu-Jun Liu
    Yong-Su Zhen
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 425 - 436
  • [6] Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8+ T cell augmentation
    Shan, Chuan-Kun
    Du, Yi-Bo
    Zhai, Xiao-Tian
    Wang, Yue-Xuan
    Li, Yi
    Gong, Jian-Hua
    Ge, Zhi-Juan
    Liu, Xiu-Jun
    Zhen, Yong-Su
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (03) : 425 - 436
  • [7] CD8+ Tumor-Infiltrating T Cells Are Trapped in the Tumor-Dendritic Cell Network
    Boissonnas, Alexandre
    Licata, Fabrice
    Poupel, Lucie
    Jacquelin, Sebastien
    Fetler, Luc
    Krumeich, Sophie
    Thery, Clotilde
    Amigorena, Sebastian
    Combadiere, Christophe
    NEOPLASIA, 2013, 15 (01): : 85 - +
  • [8] Tumor-infiltrating CD8+ T cells as a biomarker for chemotherapy efficacy in unresectable hepatocellular carcinoma
    Kuwano, Akifumi
    Yada, Masayoshi
    Miyazaki, Yoshiko
    Tanaka, Kosuke
    Kurosaka, Kazuki
    Ohishi, Yoshihiro
    Masumoto, Akihide
    Motomura, Kenta
    ONCOLOGY LETTERS, 2023, 25 (06)
  • [9] Not All Tumor-Infiltrating CD8+ T Cells Are Created Equal
    Held, Werner
    Speiser, Daniel E.
    CANCER CELL, 2021, 39 (02) : 145 - 147
  • [10] Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance
    Doedens, Andrew L.
    Rubinstein, Mark P.
    Gross, Emilie T.
    Best, J. Adam
    Craig, David H.
    Baker, Megan K.
    Cole, David J.
    Bui, Jack D.
    Goldrath, Ananda W.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (09) : 799 - 811
12345